# The MARS® Albumin Dialysis System in Patients With Fulminant and Subfulminant Hepatic Failure

> **NCT00224705** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 110 (actual)

## Conditions studied

- Hepatitis

## Interventions

- **DEVICE:** Molecular Adsorbent Recirculating System (MARS®)

## Key facts

- **NCT ID:** NCT00224705
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2011-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00224705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00224705, "The MARS® Albumin Dialysis System in Patients With Fulminant and Subfulminant Hepatic Failure". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00224705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*